267 related articles for article (PubMed ID: 7801946)
21. High risk of malignancy in familial Barrett's esophagus: presentation of one family.
Munitiz V; Parrilla P; Ortiz A; Martinez-de-Haro LF; Yelamos J; Molina J
J Clin Gastroenterol; 2008 Aug; 42(7):806-9. PubMed ID: 18385604
[TBL] [Abstract][Full Text] [Related]
22. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
Kim R; Weissfeld JL; Reynolds JC; Kuller LH
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
[TBL] [Abstract][Full Text] [Related]
23. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
24. Multiple polyposis and adenocarcinoma arising in Barrett's esophagus.
Wong RS; Temes RT; Follis FM; Kessler RM; Pett SB; Wernly JA
Ann Thorac Surg; 1996 Jan; 61(1):216-8. PubMed ID: 8561560
[TBL] [Abstract][Full Text] [Related]
25. Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
Brabender J; Lord RV; Danenberg KD; Metzger R; Schneider PM; Park JM; Salonga D; Groshen S; Tsao-Wei DD; DeMeester TR; Hölscher AH; Danenberg PV
J Surg Res; 2001 Aug; 99(2):301-6. PubMed ID: 11469901
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy for Barrett's esophagus: clinical update.
Overholt BF; Panjehpour M
Am J Gastroenterol; 1996 Sep; 91(9):1719-23. PubMed ID: 8792687
[TBL] [Abstract][Full Text] [Related]
27. Squamous carcinoma of the esophagus in patients with Barrett esophagus.
Rosengard AM; Hamilton SR
Mod Pathol; 1989 Jan; 2(1):2-7. PubMed ID: 2922388
[TBL] [Abstract][Full Text] [Related]
28. Barrett's esophagus (BE) and carcinoma in the esophageal stump (ES) after esophagectomy with gastric pull-up in achalasia patients: a study based on 10 years follow-up.
da Rocha JR; Ribeiro U; Sallum RA; Szachnowicz S; Cecconello I
Ann Surg Oncol; 2008 Oct; 15(10):2903-9. PubMed ID: 18618179
[TBL] [Abstract][Full Text] [Related]
29. Section I: epidemiological review.
Lukanich JM
Semin Thorac Cardiovasc Surg; 2003 Apr; 15(2):158-66. PubMed ID: 12838486
[TBL] [Abstract][Full Text] [Related]
30. [Barrett's esophagus. Prevalence, risk of adenocarcinoma, role of endoscopic surveillance].
Zaninotto G; Costantini M; Molena D; Rizzetto C; Ekser B; Ancona E
Minerva Chir; 2002 Dec; 57(6):819-36. PubMed ID: 12592224
[TBL] [Abstract][Full Text] [Related]
31. Barrett's esophagus and risk of esophageal adenocarcinoma.
Cossentino MJ; Wong RK
Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
[TBL] [Abstract][Full Text] [Related]
32. Tobacco smoking increases the risk of high-grade dysplasia and cancer among patients with Barrett's esophagus.
Coleman HG; Bhat S; Johnston BT; McManus D; Gavin AT; Murray LJ
Gastroenterology; 2012 Feb; 142(2):233-40. PubMed ID: 22062359
[TBL] [Abstract][Full Text] [Related]
33. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation.
Byrne JP; Armstrong GR; Attwood SE
Am J Gastroenterol; 1998 Oct; 93(10):1810-5. PubMed ID: 9772036
[TBL] [Abstract][Full Text] [Related]
34. Double early epidermoid carcinoma of the esophagus in columnar epithelium.
Resano CH; Cabrera N; Gonzalez Cueto D; Sanchez Basso AE; Rubio HH
Endoscopy; 1985 Mar; 17(2):73-5. PubMed ID: 3987636
[TBL] [Abstract][Full Text] [Related]
35. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
[TBL] [Abstract][Full Text] [Related]
36. Vitamin intake and risk of subtypes of esophageal cancer in Germany.
Bollschweiler E; Wolfgarten E; Nowroth T; Rosendahl U; Mönig SP; Hölscher AH
J Cancer Res Clin Oncol; 2002 Oct; 128(10):575-80. PubMed ID: 12384802
[TBL] [Abstract][Full Text] [Related]
37. [Gastroesophageal reflux disease and malignancy].
Richert Z; Robaszkiewicz M
Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
[TBL] [Abstract][Full Text] [Related]
38. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
39. Barrett's mucosa with multiple carcinomas of the esophagus and oral cavity.
Sheahan DG; Berman MA
J Clin Gastroenterol; 1986 Feb; 8(1):103-7. PubMed ID: 3517130
[TBL] [Abstract][Full Text] [Related]
40. Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus.
Soslow RA; Remotti H; Baergen RN; Altorki NK
Mod Pathol; 1999 Mar; 12(3):239-50. PubMed ID: 10102608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
